MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
GlaxoSmithKline plc (GSK)
Organization & Developments: GSK (GlaxoSmithKline)
*GlaxoSmithKline-GSK Center of Excellence for External Drug Discovery
ChemoCentryx, Inc., (NASDAQ:CCXI)
Organization & Developments: ChemoCentryx
Parents
ChemoCentryx, Inc., (NASDAQ:CCXI)
Children
2018: ChemoCentryx: Significant Progress In Recent Months - ChemoCentryx (NASDAQ:CCXI)
2019: ChemoCentryx_Looking to Pick Up a 45% Return by May_gallery.mailchimp.com
2019: met the primary endpoints in its Phase 3 ADVOCATE trial of avacopan, for the treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA-associated vasculitis or ANCA vasculitis).
2022: ChemoCentryx: Good Post-Approval Performance, But Needs More Time_seekingalpha.com
Jumps
*Key People: ChemoCentryx
Finance & Acquisitions: ChemoCentryx